Company Filing History:
22 out of 2,489 
4 out of 2,119 
2 out of 2,343 
Years Active: 2011-2025
Title: Ottavio Arancio: A Pioneer in Neurodegenerative Disease Research
Introduction
Ottavio Arancio is a distinguished inventor based in New York, NY, known for his substantial contributions to the field of pharmaceutical sciences. Holding a remarkable 22 patents, his work primarily focuses on innovative treatments for cancer and neurodegenerative disorders, reflecting his commitment to advancing medical science.
Latest Patents
Among his latest patents, Ottavio has developed groundbreaking inventions such as "Histone acetyltransferase activators and compositions and uses thereof." This invention encompasses pharmaceutical compositions and methods aimed at treating cancer and various neurodegenerative conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and alpha-synuclein accumulations. The methodology involves administering a HAT modulator along with a HDAC modulator to the affected subject.
Another notable patent is "Phosphodiesterase inhibitors and uses thereof," which introduces novel benzonaphthyridine derivatives. These compounds serve as phosphodiesterase inhibitors and are designed for the treatment of neurodegenerative diseases. The patent outlines methods for inhibiting phosphodiesterase through the use of these derivatives, particularly focusing on enhancing memory and long-term potentiation.
Career Highlights
Ottavio Arancio has made significant strides in his academic and professional journey, working at prestigious institutions such as Columbia University in the City of New York and Northwestern University. His roles in these esteemed organizations have propelled his research in medicinal chemistry and have facilitated the development of innovative therapeutic strategies.
Collaborations
Throughout his career, Ottavio has collaborated with prominent researchers, including Donald W. Landry and Shixian Deng. These partnerships have enriched his work and broadened the impact of his inventions in the scientific community.
Conclusion
In summary, Ottavio Arancio stands out as a leading inventor in the realm of neurodegenerative research and pharmaceutical development. With a portfolio of 22 patents, his innovative approaches to treating complex diseases continue to inspire further exploration and advancement in the field. His contributions not only reflect his expertise but also his dedication to improving the lives of patients affected by challenging medical conditions.